Excited to share that I presented our work on HbF induction by BMS-986470, a novel CELMoD agent for sickle cell disease, at the European Hematology Association (EHA) Annual …
Excited to share that our abstract on a novel Ikaros/Aiolos transcriptional signature in multiple myeloma has been accepted and will be presented at the AACR Annual Meeting 2026 …
We are excited to announce ContextMap to provide session intelligence and auto-summarize the project's evolution.
I’ll be attending NeurIPS 2025! Looking forward to connecting with the community and discussing how AI is transforming drug discovery and genomics research!
Excited to share that our work on Golcadomide, an oral CELMoD agent targeting IKZF1/3 for Diffuse Large B-Cell Lymphoma, has been published in Blood Cancer Discovery! This study …